NewsSource: EClinCloud

Product Overview | eTMF · Trial Master File Management System

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration


As more clinical trials are conducted across different regions, establishing a secure data management system keeps clinical research operations orderly and compliant with regulatory requirements, helping pharmaceutical companies obtain market access.


What Is EClinCloud eTMF?


EClinCloud eTMF is a professional-grade electronic document management system developed around actual clinical research workflows, primarily used to store, manage, and track clinical trial documents.


01

Meet Regulatory Inspection Requirements Across Countries More Easily and Effectively

EClinCloud eTMF can authentically and completely reconstruct evidence of the actions taken and decisions made during clinical trial conduct, ensuring the integrity, compliance, timeliness, and traceability of trial documents and meeting regulatory requirements across countries and regions.


Article illustration


Article illustration


02

Enable Digital and Intelligent Clinical Trial Document Management

Built on a clinical evidence support SaaS cloud platform, EClinCloud eTMF integrates seamlessly with systems such as CTMS to enable free data flow, reduce manual data entry, improve document filing efficiency, and minimize trial risk.


Article illustration



03

Meet Document Management Needs Across Different Clinical Trial Scenarios

EClinCloud eTMF supports diverse application scenarios, including sponsor team project operations, CRO project document management, regulatory inspections and audits, drug and medical device marketing application submissions, cross-regional and cross-team internal document management, long-term archiving of clinical trial documents, and post-trial document management.


Article illustration



What Are the Features of the EClinCloud eTMF System?

Article illustration


What Services Does EClinCloud eTMF Provide?

Article illustration





About EClinCloud

EClinCloud is a technology company dedicated to clinical research and development. It provides an integrated, interconnected all-in-one clinical trial cloud platform (including technology products such as eCOA, CTMS, eTMF, EDC, and RTSM, as well as solutions such as scale management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, and ophthalmology). Combining cutting-edge technology with life data, it builds a globally leading "patient-centric" clinical evidence support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.